Karyopharm Therapeutics Inc (KPTI)

Feb 27, 2025

Karyopharm Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 26, 2025

Karyopharm Therapeutics Inc.'s SWOT analysis: biotech firm's stock faces pivotal year - Investing.com

Feb 26, 2025

Feb 26, 2025

Karyopharm Therapeutics Inc.’s SWOT analysis: biotech firm’s stock faces pivotal year By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 25, 2025

Karyopharm enacts 1-for-15 reverse stock split to boost price - Investing.com Australia

Feb 25, 2025

Feb 24, 2025

Karyopharm enacts reverse stock split to meet Nasdaq standards By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Karyopharm enacts reverse stock split to meet Nasdaq standards - Investing.com

Feb 24, 2025

Feb 24, 2025

Karyopharm Unveils 1-for-15 Reverse Stock Split, Effective February 25, 2025 - Nasdaq

Feb 24, 2025

Feb 24, 2025

Karyopharm Therapeutics to Implement 1-for-15 Reverse Stock Split -February 24, 2025 at 01:18 pm EST - Marketscreener.com

Feb 24, 2025

Feb 24, 2025

Karyopharm Announces 1-for-15 Reverse Stock Split - Citizentribune

Feb 24, 2025

Feb 24, 2025

Karyopharm announces 1-for-15 reverse stock split - MSN

Feb 24, 2025

Feb 24, 2025

Karyopharm enacts 1-for-15 reverse stock split to boost price By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Can Karyopharm's 15:1 Reverse Split Save Its Nasdaq Listing? - StockTitan

Feb 24, 2025

Feb 24, 2025

Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Feb 24, 2025

Feb 23, 2025

Karyopharm Therapeutics’ (KPTI) “Buy” Rating Reiterated at HC Wainwright - Defense World

Feb 23, 2025

Feb 22, 2025

Karyopharm’s 2024 Earnings and Clinical Progress - TipRanks

Feb 22, 2025

Feb 21, 2025

Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress - MSN

Feb 21, 2025

Feb 20, 2025

H.C. Wainwright maintains Buy on Karyopharm with $7 target By Investing.com - Investing.com South Africa

Feb 20, 2025

Feb 20, 2025

Karyopharm’s Earnings Call: Growth Amid Financial Challenges - TipRanks

Feb 20, 2025

Feb 20, 2025

Karyopharm Therapeutics: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks

Feb 20, 2025

Feb 20, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Announces Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Feb 20, 2025

Feb 20, 2025

H.C. Wainwright maintains Buy on Karyopharm with $7 target - Investing.com India

Feb 20, 2025

Feb 20, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025

Feb 20, 2025

Karyopharm Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

Karyopharm Therapeutics Faces Financial Uncertainty Amid $1.6 Billion Deficit and Urgent Need for Funding - TipRanks

Feb 20, 2025

Feb 19, 2025

Karyopharm Therapeutics: Q4 Earnings Snapshot - CT Insider

Feb 19, 2025

Feb 19, 2025

Earnings call transcript: Karyopharm Q4 2024 revenue misses forecasts By Investing.com - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 19, 2025

Feb 19, 2025

Earnings call transcript: Karyopharm Q4 2024 revenue misses forecasts - Investing.com India

Feb 19, 2025

Feb 19, 2025

Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Report Previ - GuruFocus.com

Feb 19, 2025

Feb 19, 2025

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress - Victoria Advocate

Feb 19, 2025

Feb 19, 2025

Karyopharm Therapeutics: Q4 Earnings Snapshot -February 19, 2025 at 07:46 am EST - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Karyopharm Therapeutics Inc. SEC 10-K Report - TradingView

Feb 19, 2025

Feb 19, 2025

Karyopharm Therapeutics Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 19, 2025

Feb 18, 2025

Karyopharm Therapeutics' SWOT analysis: stock potential amid clinical trials - Investing.com India

Feb 18, 2025

Feb 18, 2025

Karyopharm Therapeutics' SWOT analysis: stock potential amid clinical trials By Investing.com - Investing.com Nigeria

Feb 18, 2025

Feb 18, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Share Price Crosses Below 200-Day Moving AverageWhat's Next? - MarketBeat

Feb 18, 2025

Feb 14, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Earns "Outperform" Rating from Royal Bank of Canada - MarketBeat

Feb 14, 2025

Feb 12, 2025

Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - Citizentribune

Feb 12, 2025

Feb 11, 2025

Did Karyopharm Therapeutics Inc (KPTI) perform well in the last session? - US Post News

Feb 11, 2025

Feb 11, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Given “Outperform” Rating at Royal Bank of Canada - Defense World

Feb 11, 2025

Feb 08, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Share Price Passes Below 200 Day Moving AverageWhat's Next? - MarketBeat

Feb 08, 2025

Feb 08, 2025

Karyopharm Therapeutics Inc (NASDAQ: KPTI) Shares Fall By 1.43 Percent In The Past Week, But How Long Will It Last? – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025